Product Information
MOMETASONE FUROATE 0.1% OINT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.2926 per GM under NDC 45802011937. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Mar 18, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/g
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802011937
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA076067FDA Approved
3/18/2002
TE Code
AB
On Market Since
7/18/2008
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% OINT has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 29.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2926 per GM |
|---|---|
| All-time high | $0.6681 (Feb 12, 2014) |
| All-time low | $0.2383 (Jan 22, 2020) |
| 52-week high | $0.3489 |
| 52-week low | $0.2926 |
| Median price | $0.3318 |
| Average price | $0.3610 |
| Largest weekly change | +49.7% (Jan 22, 2014) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% OINT?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% OINT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.2926 per GM (NDC 45802011937), effective Aug 19, 2026.
How has the price of MOMETASONE FUROATE 0.1% OINT changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% OINT has declined 29.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% OINT?
Since Nov 28, 2013, the NADAC for MOMETASONE FUROATE 0.1% OINT has ranged from a low of $0.2383 (Jan 22, 2020) to a high of $0.6681 (Feb 12, 2014), with a median of $0.3318 per GM.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% OINT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% OINT, is $0.2029 per GM — about 31% below MOMETASONE FUROATE 0.1% OINT.
Who manufactures MOMETASONE FUROATE 0.1% OINT?
MOMETASONE FUROATE 0.1% OINT (NDC 45802011937) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.